Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts

Journal of Veterinary Diagnostic Investigation

Volumn 15, Issue 4, 2003, Pages 338-343

  Cohn, Leah A ^a   Gary, Anthony T ^a   Fales, William H ^b   Madsen, Richard W ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; ESCHERICHIA COLI; MIRABILIS; PROTEUS MIRABILIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS INTERMEDIUS; STREPTOCOCCUS;

ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; DOG; DOG DISEASE; DRUG EFFECT; ESCHERICHIA COLI; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PATHOGENICITY; PREVALENCE; PROTEUS MIRABILIS; STAPHYLOCOCCUS; URINARY TRACT INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEMALE; FLUOROQUINOLONES; MALE; PREVALENCE; PROTEUS MIRABILIS; STAPHYLOCOCCUS; URINARY TRACT INFECTIONS;

EID: 0041382380     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870301500406     Document Type: Article

References (23)

1. Brown SA: 1996, Fluoroquinolones in animal health. J Vet Pharmacol Therap 19:1-14.
2. Cooke CL, Singer RS, Jang SS, Hirsh DC: 2002, Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections. J Am Vet Med Assoc 220:190-192.
3. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla E: 1999, Comparative studies of mutations in animal isolates and experimental in vitro-and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 43:2131-2137.
4. Goettsch W, van Pelt W, Nagelkerke N, et al.: 2000, Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 46: 223-228.
5. Hoffman SB: 2001, Mechanisms of antibiotic resistance. Compend Contin Educ Pract Vet 23:464-473.
6. Kung K, Riond JL, Wanner M: 1993, Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J Vet Pharmacol Ther 16:462-468.
7. Ling GV, Norris CR, Franti CE, et al.: 2001, Interrelations of organism prevalence, specimen collection method, and host age, sex, and breed among 8, 354 canine urinary tract infections (1969-1995). J Vet Intern Med 15:341-347.
8. Livermore DM, James D, Reacher M, et al.: 2002, Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg Infect Dis 8:473-478.
9. Malorny B, Schroeter A, Helmuth R: 1999, Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany. Antimicrob Agents Chemother 43:2278-2282.
10. National Committee for Clinical Laboratory Standards (NCCLS): 1997, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed., approved standard M7-4, Wayne, PA.
11. Neu HC: 1988, Bacterial resistance to fluoroquinolones. Rev Infect Dis 10:S57-S63.
12. O'Donnell JA, Gelone SP: 2000, Fluoroquinolones. Infect Dis Clin N Am 14:489-513.
13. Oluoch AO, Kim CH, Weisiger RM, et al.: 2001, Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998). J Am Vet Med Assoc 218:381-384.
14. Patten VH, Shin SJ, Cole J, et al.: 1995, Evaluation of a commercial automated system and software for the identification of veterinary bacterial isolates. J Vet Diagn Invest 7:506-508.
15. Piddock LJ: 1998, Fluoroquinolone resistance: overuse of fluoroquinolones in human and veterinary medicine can breed resistance. Br Med J 317:1029-1030.
16. Piddock LJ: 1999, Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 58S2:11-18.
17. Piddock LJ, Jin YF, Ricci V, Asuquo AE: 1999, Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli. J Antimicrob Chemother 43:61-70.
18. Pieroni P, Goodfellow J, Reesor L, et al.: 1997, Antimicrobial susceptibilities of blood culture isolates obtained before and after the introduction of ciprofloxacin. J Antimicrob Chemother 39:419-422.
19. Polzin DJ: 1999, Therapy of canine and feline urinary tract infections with enrofloxacin. Compend Contin Educ Pract Vet 21: 65-72.
20. Quinn PJ, Carter ME, Markey BK, Carter GR: 1994, Microscopy, culture, and identification. In: Clinical veterinary microbiology, ed. Quinn PJ, Carter ME, Markey BK, Carter GR, pp. 21-67. Mosby Year Book Europe, Ltd., London, UK.
21. Thomson CJ: 1999, The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective. J Antimicrob Chemother 43(Suppl.)A:31-40.
22. Vromen M, van der Ven AJ, Knols A, Stobberingh EE: 1999, Antimicrobial resistance patterns in urinary isolates from nursing home residents. Fifteen years of data reviewed. J Antimicrob Chemother 44:113-116.
23. Walker RD, Thornsberry C: 1998, Decrease in antibiotic susceptibility or increase in resistance? J Antimicrob Chemother 41:1-4.